{
  "id": "acute-tbi-management",
  "title": "Acute Traumatic Brain Injury Management",
  "version": "1.0",
  "icd10": [
    "** S06.9X0A (Unspecified intracranial injury without loss of consciousness",
    "initial)",
    "S06.2X0A (Diffuse TBI without LOC",
    "initial)",
    "S06.5X0A (Traumatic subdural hemorrhage without LOC",
    "initial)",
    "S06.4X0A (Epidural hemorrhage without LOC",
    "initial)",
    "S06.6X0A (Traumatic subarachnoid hemorrhage without LOC",
    "initial)",
    "S06.1X0A (Traumatic cerebral edema without LOC",
    "initial)",
    "S06.300A (Unspecified focal TBI without LOC",
    "initial)"
  ],
  "scope": "** Acute evaluation and management of traumatic brain injury in adults within the first 72 hours. Covers initial assessment (GCS, primary/secondary survey), neuroimaging decision rules, medical management of elevated ICP, seizure prophylaxis, coagulopathy reversal, non-surgical subdural/epidural management, and neurosurgical consultation criteria. Applies to ED, hospital, and ICU settings (acute phase — no outpatient). Excludes post-concussion syndrome (separate plan — chronic recovery phase), penetrating brain injury, pediatric TBI, and chronic subdural hematoma management.",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Core Labs (Immediate)": [
        {
          "item": "CBC with differential (85025)",
          "ED": "STAT",
          "HOSP": "STAT",
          "ICU": "STAT",
          "rationale": "Baseline hemoglobin/hematocrit; thrombocytopenia increases hemorrhage risk; leukocytosis may indicate stress response or infection",
          "target": "Platelets >100,000 for ICP monitor placement; Hgb >7 (>10 if active hemorrhage)"
        },
        {
          "item": "CMP — BMP + LFTs (80053)",
          "ED": "STAT",
          "HOSP": "STAT",
          "ICU": "STAT",
          "rationale": "Electrolytes (sodium critical for osmotherapy), glucose, renal function (mannitol safety), hepatic function (drug metabolism)",
          "target": "Na 135-145 baseline; BUN/Cr for mannitol clearance; glucose 140-180"
        },
        {
          "item": "PT/INR, aPTT (85610, 85730)",
          "ED": "STAT",
          "HOSP": "STAT",
          "ICU": "STAT",
          "rationale": "Coagulopathy assessment; anticoagulant reversal decisions; procedural safety",
          "target": "INR <1.4 for ICP monitor/EVD placement; aPTT <40 sec"
        },
        {
          "item": "Fibrinogen (85384)",
          "ED": "STAT",
          "HOSP": "STAT",
          "ICU": "STAT",
          "rationale": "DIC assessment in severe TBI; coagulopathy from tissue factor release",
          "target": "Target >150 mg/dL; replace if <200 in active hemorrhage"
        },
        {
          "item": "Blood glucose (82947)",
          "ED": "STAT",
          "HOSP": "STAT",
          "ICU": "STAT",
          "rationale": "Both hypoglycemia and hyperglycemia worsen outcomes in TBI; secondary injury prevention",
          "target": "Target 140-180 mg/dL; avoid <70 and >200"
        },
        {
          "item": "Type and screen (86900)",
          "ED": "STAT",
          "HOSP": "STAT",
          "ICU": "STAT",
          "rationale": "Surgical candidacy; blood product availability; transfusion readiness",
          "target": "Blood available within 30 min if needed"
        },
        {
          "item": "Serum osmolality (83930)",
          "ED": "STAT",
          "HOSP": "STAT",
          "ICU": "STAT",
          "rationale": "Baseline before osmotherapy; guides mannitol and hypertonic saline dosing",
          "target": "Target 300-320 during osmotherapy; do NOT exceed 320"
        },
        {
          "item": "Sodium (84295)",
          "ED": "STAT",
          "HOSP": "STAT",
          "ICU": "STAT",
          "rationale": "Baseline; critical for hypertonic saline therapy; osmolar gap calculation",
          "target": "Target 145-155 mEq/L during ICP crisis; avoid >160"
        },
        {
          "item": "ABG/VBG (82803)",
          "ED": "STAT",
          "HOSP": "-",
          "ICU": "STAT",
          "rationale": "Ventilation status; PaCO2 critical for ICP management; oxygenation assessment",
          "target": "PaCO2 35-40 (normocapnia); PaO2 >60; pH 7.35-7.45"
        },
        {
          "item": "Lactate (83605)",
          "ED": "STAT",
          "HOSP": "STAT",
          "ICU": "STAT",
          "rationale": "Tissue perfusion marker; polytrauma assessment; occult shock detection",
          "target": "<2 mmol/L; elevated suggests inadequate perfusion"
        },
        {
          "item": "Blood alcohol level (80320)",
          "ED": "STAT",
          "HOSP": "-",
          "ICU": "-",
          "rationale": "Confounds neurological exam; present in 30-50% of TBI patients; may explain altered mental status",
          "target": "Document level; reassess GCS when metabolized"
        },
        {
          "item": "Troponin (84484)",
          "ED": "STAT",
          "HOSP": "STAT",
          "ICU": "STAT",
          "rationale": "Neurogenic cardiac injury; stress cardiomyopathy in severe TBI; catecholamine surge",
          "target": "Elevated troponin → echocardiogram; rule out neurogenic stunned myocardium"
        }
      ],
      "Extended Labs": [
        {
          "item": "Serum osmolality — serial (83930)",
          "ED": "-",
          "HOSP": "URGENT q4-6h",
          "ICU": "URGENT q4-6h",
          "rationale": "Monitor during osmotherapy to prevent renal injury and rebound cerebral edema",
          "target": "Maintain <320 mOsm/kg; hold mannitol if ≥320"
        },
        {
          "item": "Sodium — serial (84295)",
          "ED": "-",
          "HOSP": "URGENT q2-6h",
          "ICU": "URGENT q2-6h",
          "rationale": "Track sodium correction during hypertonic saline; avoid overcorrection",
          "target": "Target 145-155 during ICP crisis; do not exceed 160; correct no faster than 8-10 mEq/24h when weaning"
        },
        {
          "item": "Cortisol, AM (82533)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "ICU": "ROUTINE",
          "rationale": "Pituitary injury screening; trauma-related hypopituitarism occurs in 30-40% severe TBI; adrenal insufficiency",
          "target": "AM cortisol <10 mcg/dL suggests adrenal insufficiency → stimulation testing"
        },
        {
          "item": "TSH, free T4 (84443, 84439)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "ICU": "ROUTINE",
          "rationale": "Pituitary injury screening; central hypothyroidism from hypothalamic-pituitary trauma",
          "target": "Low free T4 with low/normal TSH suggests central hypothyroidism"
        },
        {
          "item": "D-dimer (85379)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "ICU": "URGENT",
          "rationale": "DIC screening in severe TBI; traumatic coagulopathy common",
          "target": "Elevated → check fibrinogen, peripheral smear; trend with serial labs"
        },
        {
          "item": "Blood cultures (87040)",
          "ED": "STAT if febrile",
          "HOSP": "STAT if febrile",
          "ICU": "STAT if febrile",
          "rationale": "Infection surveillance; VAP, line infection, aspiration pneumonia common in ICU TBI patients",
          "target": "Positive → targeted antibiotic therapy; assess for VAP if intubated"
        },
        {
          "item": "Phenytoin level (80185)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "ICU": "ROUTINE",
          "rationale": "Therapeutic drug monitoring if on phenytoin for seizure prophylaxis; narrow therapeutic index",
          "target": "Target total 10-20 mcg/mL or free 1-2 mcg/mL; levetiracetam does NOT require monitoring"
        }
      ],
      "Specialized Labs": [
        {
          "item": "Thromboelastography (TEG) / ROTEM",
          "ED": "-",
          "HOSP": "-",
          "ICU": "URGENT",
          "rationale": "Functional coagulation assessment; identifies specific coagulation deficits; guides targeted blood product use in severe TBI",
          "target": "Guides platelet, FFP, cryoprecipitate, TXA use; more informative than standard coag panel"
        },
        {
          "item": "GFAP, UCH-L1 serum biomarkers (if available) (0306U)",
          "ED": "URGENT",
          "HOSP": "-",
          "ICU": "-",
          "rationale": "FDA-approved biomarkers to rule out CT-visible intracranial lesion in mild TBI (GCS 13-15); may reduce unnecessary CT",
          "target": "Negative predictive value >99% for CT-visible lesion; does NOT replace CT if clinically indicated"
        },
        {
          "item": "CSF analysis — if EVD placed (89050, 89051, 87070)",
          "ED": "-",
          "HOSP": "-",
          "ICU": "STAT",
          "rationale": "Culture, cell count, glucose, protein for infection surveillance; ventriculitis risk with EVD is 5-10%",
          "target": "WBC >5, low glucose, positive culture → ventriculitis; daily CSF sampling per protocol"
        }
      ]
    },
    "Imaging & Studies": {
      "Essential / First-line": [
        {
          "item": "CT head without contrast (70450)",
          "ED": "STAT",
          "HOSP": "STAT",
          "ICU": "STAT",
          "timing": "IMMEDIATE — within 30 minutes of arrival; any GCS <15, LOC, amnesia, vomiting, age >65, coagulopathy, dangerous mechanism (Canadian CT Head Rule / New Orleans Criteria)",
          "target": "Hemorrhage (SDH, EDH, SAH, contusion), midline shift (>5 mm = significant), cerebral edema, skull fracture, pneumocephalus",
          "contraindications": "None in acute trauma — benefit always outweighs radiation risk"
        },
        {
          "item": "CT cervical spine (72125)",
          "ED": "STAT",
          "HOSP": "-",
          "ICU": "STAT",
          "timing": "IMMEDIATE — assume concomitant c-spine injury until cleared; NEXUS or Canadian C-Spine Rule to determine need",
          "target": "Fracture, subluxation, ligamentous injury, prevertebral soft tissue swelling",
          "contraindications": "None in acute trauma"
        },
        {
          "item": "CT angiography head/neck (70496, 70498)",
          "ED": "STAT",
          "HOSP": "-",
          "ICU": "STAT",
          "timing": "Within 1 hour if vascular injury suspected — Denver screening criteria: skull base fracture, cervical spine fracture, Horner syndrome, Le Fort II/III, neck soft tissue injury",
          "target": "Dissection, traumatic pseudoaneurysm, arteriovenous fistula, vessel occlusion",
          "contraindications": "Contrast allergy (premedicate if critical); renal insufficiency (benefit > risk in acute setting)"
        },
        {
          "item": "Chest X-ray (71046)",
          "ED": "STAT",
          "HOSP": "STAT",
          "ICU": "STAT",
          "timing": "Within 30 minutes — polytrauma assessment; confirm ETT position if intubated",
          "target": "Pneumothorax, hemothorax, rib fractures, aspiration, mediastinal widening, ETT placement verification",
          "contraindications": "None"
        }
      ],
      "Extended (After Stabilization)": [
        {
          "item": "MRI brain with DWI/SWI (70553)",
          "ED": "-",
          "HOSP": "URGENT",
          "ICU": "URGENT",
          "timing": "When hemodynamically stable — typically 24-72h; superior for DAI (SWI sequences), brainstem injury, petechial hemorrhages",
          "target": "Diffuse axonal injury (microhemorrhages on SWI), brainstem lesions, cerebral edema extent, prognostic information",
          "contraindications": "Unstable patient, non-MRI-compatible ICP monitor/EVD, ferromagnetic implants, hemodynamic instability"
        },
        {
          "item": "Repeat CT head (70450)",
          "ED": "STAT",
          "HOSP": "STAT",
          "ICU": "STAT",
          "timing": "6-8 hours after initial CT or immediately with any neurological change; 30% of traumatic SDH/EDH expand on repeat imaging",
          "target": "Hemorrhage expansion, new hemorrhage, increased edema, evolving midline shift",
          "contraindications": "None"
        },
        {
          "item": "CT angiography head (70496)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "ICU": "URGENT",
          "timing": "If expanding hemorrhage, delayed neurological decline, or concern for vascular injury not previously assessed",
          "target": "Vascular injury, pseudoaneurysm, active extravasation, vasospasm (traumatic SAH)",
          "contraindications": "Contrast allergy; renal insufficiency (benefit > risk if clinically indicated)"
        }
      ],
      "Specialized": [
        {
          "item": "ICP monitor — intraparenchymal or EVD (61107, 61210)",
          "ED": "-",
          "HOSP": "-",
          "ICU": "STAT",
          "timing": "Severe TBI (GCS ≤8) with abnormal CT; OR GCS ≤8 with normal CT if age >40, motor posturing, or SBP <90 (BTF guidelines)",
          "target": "ICP >22 mmHg (BTF 4th edition threshold); guides osmotherapy, sedation, surgical decompression; EVD allows therapeutic CSF drainage",
          "contraindications": "Coagulopathy (INR >1.4, platelets <100K — correct first); scalp infection at insertion site"
        },
        {
          "item": "Continuous EEG (95816, 95950)",
          "ED": "-",
          "HOSP": "URGENT",
          "ICU": "STAT",
          "timing": "If unexplained neurological decline, witnessed or suspected seizure, GCS does not improve as expected; subclinical seizures occur in 10-20% of severe TBI",
          "target": "Non-convulsive seizures, non-convulsive status epilepticus, epileptiform discharges; guides antiepileptic therapy",
          "contraindications": "None; critical for unexplained decline in TBI"
        },
        {
          "item": "Transcranial Doppler (93886)",
          "ED": "-",
          "HOSP": "URGENT",
          "ICU": "URGENT",
          "timing": "Non-invasive ICP estimation; assess for cerebral vasospasm in traumatic SAH; serial monitoring",
          "target": "Elevated mean flow velocities (vasospasm); pulsatility index correlates with ICP; loss of diastolic flow (critically elevated ICP)",
          "contraindications": "Inadequate temporal bone window (10-15% of patients); operator dependent"
        }
      ]
    },
    "Treatment": {
      "Immediate Stabilization (All TBI)": [
        {
          "item": "Airway management / Intubation",
          "route": "ETT",
          "indication": "GCS ≤8; inability to protect airway; respiratory failure; impending herniation",
          "dosing": {
            "instructions": "RSI: Etomidate 0.3 mg/kg IV or Ketamine 1-2 mg/kg IV (ketamine does NOT raise ICP per modern evidence) + Succinylcholine 1.5 mg/kg IV or Rocuronium 1.2 mg/kg IV",
            "orderSentence": "Airway management / Intubation - ETT - see dosing"
          },
          "contraindications": "Ketamine: none (safe in TBI); Succinylcholine: hyperkalemia, burns, denervation injury",
          "monitoring": "EtCO2, SpO2, PaCO2 on ABG",
          "ED": "STAT",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "C-spine immobilization",
          "route": "Cervical collar",
          "indication": "ALL TBI patients until c-spine cleared clinically or by imaging",
          "dosing": {
            "instructions": "Rigid cervical collar; maintain in-line stabilization during intubation",
            "orderSentence": "C-spine immobilization - Cervical collar - see dosing"
          },
          "contraindications": "None",
          "monitoring": "Clinical exam, imaging clearance",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "IV fluids — Normal Saline preferred",
          "route": "IV",
          "indication": "Maintain euvolemia; prevent hypotension (SBP <90 doubles mortality in severe TBI)",
          "dosing": {
            "doseOptions": [
              {
                "text": "NS bolus 500-1000 mL",
                "orderSentence": "IV fluids — Normal Saline preferred NS bolus 500-1000 mL IV"
              }
            ],
            "route": "IV",
            "instructions": "target euvolemia; avoid hypotonic fluids (worsen cerebral edema)",
            "orderSentence": "IV fluids — Normal Saline preferred NS bolus 500-1000 mL IV"
          },
          "contraindications": "Avoid LR (slightly hypotonic); avoid D5W (hypotonic, worsens edema)",
          "monitoring": "MAP, urine output, CVP if available",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Head of bed elevation",
          "route": "Positioning",
          "indication": "ALL TBI patients",
          "dosing": {
            "doseOptions": [
              {
                "text": "30 degrees",
                "orderSentence": "Head of bed elevation 30 degrees head of bed"
              }
            ],
            "route": "head of bed",
            "instructions": "promotes venous drainage, reduces ICP",
            "orderSentence": "Head of bed elevation 30 degrees head of bed"
          },
          "contraindications": "Contraindicated if unstable spinal fracture until cleared",
          "monitoring": "ICP trend if monitored",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Blood pressure target",
          "route": "IV vasopressors PRN",
          "indication": "Prevent secondary brain injury from hypotension",
          "dosing": {
            "doseOptions": [
              {
                "text": "SBP >100 mmHg (age 50-69)",
                "orderSentence": "Blood pressure target SBP >100 mmHg (age 50-69) SBP >110 mmHg (age 15-49)"
              }
            ],
            "route": "SBP >110 mmHg (age 15-49)",
            "instructions": "BTF guidelines; use norepinephrine or phenylephrine if needed",
            "orderSentence": "Blood pressure target SBP >100 mmHg (age 50-69) SBP >110 mmHg (age 15-49)"
          },
          "contraindications": "Avoid excessive hypertension if uncontrolled hemorrhage elsewhere",
          "monitoring": "Arterial line (preferred in ICU), continuous BP monitoring",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Temperature management",
          "route": "Cooling measures PRN",
          "indication": "Fever worsens secondary brain injury; increases ICP and metabolic demand",
          "dosing": {
            "doseOptions": [
              {
                "text": "Target normothermia 36-37.5°C",
                "orderSentence": "Temperature management Target normothermia 36-37.5°C surface cooling, acetaminophen 1g IV/PO q6h"
              }
            ],
            "route": "surface cooling, acetaminophen 1g IV/PO q6h",
            "instructions": "Target normothermia 36-37.5°C :: surface cooling, acetaminophen 1g IV/PO q6h :: treat fever aggressively",
            "orderSentence": "Temperature management Target normothermia 36-37.5°C surface cooling, acetaminophen 1g IV/PO q6h"
          },
          "contraindications": "Avoid therapeutic hypothermia (EUROTHERM, POLAR trials showed no benefit or harm)",
          "monitoring": "Continuous core temperature (esophageal, bladder, or rectal probe)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Glucose management",
          "route": "IV insulin PRN",
          "indication": "Hyperglycemia and hypoglycemia both worsen TBI outcomes; secondary injury prevention",
          "dosing": {
            "doseOptions": [
              {
                "text": "Target 140-180 mg/dL",
                "orderSentence": "Glucose management Target 140-180 mg/dL IV insulin drip if >180"
              }
            ],
            "route": "IV insulin drip if >180",
            "instructions": "avoid tight glucose control (<110) per NICE-SUGAR",
            "orderSentence": "Glucose management Target 140-180 mg/dL IV insulin drip if >180"
          },
          "contraindications": "Avoid hypoglycemia (<70 mg/dL) — causes additional neuronal injury",
          "monitoring": "Point-of-care glucose q1-2h during insulin infusion",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        }
      ],
      "ICP Management (Elevated ICP or Severe TBI)": [
        {
          "item": "Mannitol 20%",
          "route": "IV",
          "indication": "First-line osmotherapy for elevated ICP (>22 mmHg); acute herniation signs (pupil dilation, posturing)",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.25-1 g/kg",
                "orderSentence": "Mannitol 20% 0.25-1 g/kg IV"
              }
            ],
            "route": "IV",
            "instructions": "q4-6h PRN",
            "orderSentence": "Mannitol 20% 0.25-1 g/kg IV"
          },
          "contraindications": "SBP <90 (mannitol causes diuresis → hypotension); serum osmolality >320; renal failure; hypovolemia",
          "monitoring": "Serum osmolality q4-6h; I&O; sodium; renal function; ICP response",
          "ED": "STAT",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Hypertonic saline 23.4%",
          "route": "IV central line ONLY",
          "indication": "Acute ICP crisis; alternative to mannitol; preferred if hypotensive (does not cause diuresis)",
          "dosing": {
            "doseOptions": [
              {
                "text": "30 mL",
                "orderSentence": "Hypertonic saline 23.4% 30 mL IV"
              }
            ],
            "route": "IV",
            "instructions": "via central line only",
            "orderSentence": "Hypertonic saline 23.4% 30 mL IV"
          },
          "contraindications": "Hypernatremia >160; CHF (volume expansion); must have central venous access",
          "monitoring": "Sodium q2-4h; serum osmolality; ICP response; cardiac monitoring",
          "ED": "STAT",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Hypertonic saline 3%",
          "route": "IV peripheral or central",
          "indication": "ICP elevation; moderate osmotherapy; can be continuous infusion",
          "dosing": {
            "doseOptions": [
              {
                "text": "250 mL",
                "orderSentence": "Hypertonic saline 3% 250 mL IV"
              }
            ],
            "route": "IV",
            "instructions": "via peripheral or central",
            "orderSentence": "Hypertonic saline 3% 250 mL IV"
          },
          "contraindications": "Hypernatremia >160; CHF; monitor closely",
          "monitoring": "Sodium q4-6h; serum osmolality; ICP",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Hyperventilation (controlled)",
          "route": "Mechanical ventilation",
          "indication": "TEMPORARY measure ONLY for acute ICP crisis or impending herniation (max 30 min)",
          "dosing": {
            "doseOptions": [
              {
                "text": "Target PaCO2 30-35 mmHg",
                "orderSentence": "Hyperventilation (controlled) Target PaCO2 30-35 mmHg adjust ventilator RR"
              }
            ],
            "route": "adjust ventilator RR",
            "instructions": "causes cerebral vasoconstriction → reduced CBF",
            "orderSentence": "Hyperventilation (controlled) Target PaCO2 30-35 mmHg adjust ventilator RR"
          },
          "contraindications": "Prolonged use (>30 min) → cerebral ischemia; rebound ICP elevation worse than baseline",
          "monitoring": "Continuous EtCO2; ABG q15-30 min during hyperventilation; ICP",
          "ED": "STAT",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Sedation/analgesia",
          "route": "IV continuous infusion",
          "indication": "Reduces metabolic demand and ICP; prevents agitation-related ICP spikes; ventilator synchrony",
          "dosing": {
            "doseOptions": [
              {
                "text": "Propofol 20-75 mcg/kg/min",
                "orderSentence": "Sedation/analgesia Propofol 20-75 mcg/kg/min IV"
              }
            ],
            "route": "IV",
            "instructions": "(check triglycerides q24-48h); Fentanyl 25-100 mcg/hr",
            "orderSentence": "Sedation/analgesia Propofol 20-75 mcg/kg/min IV"
          },
          "contraindications": "Propofol: hemodynamic instability, propofol infusion syndrome (>5 mg/kg/hr or >48h); egg/soy allergy",
          "monitoring": "Daily sedation vacation for neurological exam; ICP during exam; triglycerides (propofol)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Neuromuscular blockade",
          "route": "IV continuous infusion",
          "indication": "Last resort for refractory ICP elevation; prevents coughing, straining, ventilator dyssynchrony",
          "dosing": {
            "doseOptions": [
              {
                "text": "Cisatracurium 1-3 mcg/kg/min",
                "orderSentence": "Neuromuscular blockade Cisatracurium 1-3 mcg/kg/min IV"
              }
            ],
            "route": "IV",
            "instructions": "dose to train-of-four 1-2/4",
            "orderSentence": "Neuromuscular blockade Cisatracurium 1-3 mcg/kg/min IV"
          },
          "contraindications": "Cannot perform neurological exam during paralysis; requires continuous EEG; ICU only",
          "monitoring": "Train-of-four monitoring; continuous EEG mandatory; ICP trend",
          "ED": "-",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "CSF drainage via EVD",
          "route": "External ventricular drain",
          "indication": "Most effective single ICP reduction intervention; if EVD in place",
          "dosing": {
            "doseOptions": [
              {
                "text": "Drain 5-10 mL",
                "orderSentence": "CSF drainage via EVD Drain 5-10 mL increments"
              }
            ],
            "route": "increments",
            "instructions": "clamp and recheck; or continuous drainage at prescribed level",
            "orderSentence": "CSF drainage via EVD Drain 5-10 mL increments"
          },
          "contraindications": "EVD not placed; ventriculitis; system malfunction",
          "monitoring": "CSF output; ICP waveform; CSF appearance (infection surveillance); daily CSF cell count/culture",
          "ED": "-",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        }
      ],
      "Seizure Prophylaxis": [
        {
          "item": "Levetiracetam (Keppra) — first-line",
          "route": "IV then PO",
          "indication": "Early seizure prophylaxis for all moderate-severe TBI; cortical contusions; SDH; depressed skull fracture",
          "dosing": {
            "doseOptions": [
              {
                "text": "1000 mg",
                "orderSentence": "Levetiracetam (Keppra) — first-line 1000 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "then 500-1000 mg IV/PO q12h x 7 days",
            "orderSentence": "Levetiracetam (Keppra) — first-line 1000 mg IV"
          },
          "contraindications": "Renal dosing required if CrCl <50; behavioral side effects (agitation — common in TBI population)",
          "monitoring": "Clinical seizure activity; continuous EEG if available; renal function",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Phenytoin / Fosphenytoin — alternative",
          "route": "IV",
          "indication": "Alternative to levetiracetam; historical standard per Temkin 1990",
          "dosing": {
            "doseOptions": [
              {
                "text": "20 mg PE/kg",
                "orderSentence": "Phenytoin / Fosphenytoin — alternative 20 mg PE/kg IV"
              }
            ],
            "route": "IV",
            "instructions": "then 5 mg/kg/day divided q8h",
            "orderSentence": "Phenytoin / Fosphenytoin — alternative 20 mg PE/kg IV"
          },
          "contraindications": "Cardiac conduction disease; hepatic impairment; numerous drug interactions",
          "monitoring": "Free phenytoin level at 24h then q48-72h; cardiac monitoring during load; hepatic function",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        }
      ],
      "Coagulopathy Reversal": [
        {
          "item": "4-factor PCC (Kcentra) + Vitamin K",
          "route": "IV",
          "indication": "Warfarin reversal (elevated INR) in TBI with intracranial hemorrhage",
          "dosing": {
            "doseOptions": [
              {
                "text": "PCC 25-50 IU/kg",
                "orderSentence": "4-factor PCC (Kcentra) + Vitamin K PCC 25-50 IU/kg IV"
              }
            ],
            "route": "IV",
            "instructions": "STAT + Vitamin K 10 mg",
            "orderSentence": "4-factor PCC (Kcentra) + Vitamin K PCC 25-50 IU/kg IV"
          },
          "contraindications": "Active DIC (relative); heparin-induced thrombocytopenia (caution)",
          "monitoring": "INR <1.4 within 30 minutes; repeat INR at 30 min and 6h; monitor for thrombotic events",
          "ED": "STAT",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Idarucizumab (Praxbind)",
          "route": "IV",
          "indication": "Dabigatran (Pradaxa) reversal in TBI with intracranial hemorrhage",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 g",
                "orderSentence": "Idarucizumab (Praxbind) 5 g IV"
              }
            ],
            "route": "IV",
            "instructions": "no more than 15 min apart",
            "orderSentence": "Idarucizumab (Praxbind) 5 g IV"
          },
          "contraindications": "None absolute; hereditary fructose intolerance (contains sorbitol)",
          "monitoring": "Immediate reversal of dabigatran effect; dTT or ECT if available; clinical hemostasis assessment",
          "ED": "STAT",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Andexanet alfa (Andexxa)",
          "route": "IV",
          "indication": "Rivaroxaban / Apixaban reversal in TBI with intracranial hemorrhage (preferred); 4-factor PCC 50 IU/kg IV if andexanet unavailable",
          "dosing": {
            "doseOptions": [
              {
                "text": "Andexxa",
                "orderSentence": "Andexanet alfa (Andexxa) Andexxa IV"
              }
            ],
            "route": "IV",
            "instructions": "bolus + infusion based on dose/timing of last Xa inhibitor",
            "orderSentence": "Andexanet alfa (Andexxa) Andexxa IV"
          },
          "contraindications": "History of thrombotic events (relative — high thrombotic risk); monitor closely",
          "monitoring": "Anti-Xa levels if available; clinical hemostasis; monitor for thrombotic complications",
          "ED": "STAT",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Platelet transfusion",
          "route": "IV",
          "indication": "Antiplatelet agents (aspirin, clopidogrel) in TBI requiring neurosurgical intervention; routine transfusion NOT recommended (PATCH trial)",
          "dosing": {
            "doseOptions": [
              {
                "text": "1 apheresis unit",
                "orderSentence": "Platelet transfusion 1 apheresis unit IV"
              }
            ],
            "route": "IV",
            "instructions": "if neurosurgical intervention needed",
            "orderSentence": "Platelet transfusion 1 apheresis unit IV"
          },
          "contraindications": "Heparin-induced thrombocytopenia; TTP (relative)",
          "monitoring": "Functional platelet activity; platelet count post-transfusion; neurosurgical clearance",
          "ED": "URGENT",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "URGENT"
        },
        {
          "item": "Tranexamic acid (TXA)",
          "route": "IV",
          "indication": "Active intracranial bleeding in mild-moderate TBI (CRASH-3 trial); benefit ONLY if given within 3 hours of injury",
          "dosing": {
            "doseOptions": [
              {
                "text": "1 g",
                "orderSentence": "Tranexamic acid (TXA) 1 g IV"
              }
            ],
            "route": "IV",
            "instructions": "then 1 g",
            "orderSentence": "Tranexamic acid (TXA) 1 g IV"
          },
          "contraindications": "Severe TBI (GCS <9 — no benefit per CRASH-3); >3 hours from injury; active thromboembolic disease; seizure history (relative)",
          "monitoring": "Hemorrhage progression on repeat CT; coagulation panel; clinical neurological status",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        }
      ],
      "Non-Surgical Subdural Hematoma Management": [
        {
          "item": "Non-surgical observation",
          "route": "-",
          "indication": "SDH <10 mm thickness, midline shift <5 mm, GCS ≥9, no neurological deterioration, no anticoagulation (or successfully reversed)",
          "dosing": {
            "doseOptions": [
              {
                "text": "Continuous neuro monitoring",
                "orderSentence": "Non-surgical observation Continuous neuro monitoring -"
              }
            ],
            "route": "-",
            "instructions": "admit to ICU or step-down for serial neuro exams",
            "orderSentence": "Non-surgical observation Continuous neuro monitoring -"
          },
          "contraindications": "Thickness >10 mm; midline shift >5 mm; GCS decline ≥2 points; neurological deterioration (→ surgical referral)",
          "monitoring": "GCS q1h; pupil checks q1h; vital signs continuous; ICP if monitored",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Serial CT imaging",
          "route": "-",
          "indication": "All non-surgical SDH patients; hemorrhage surveillance",
          "dosing": {
            "doseOptions": [
              {
                "text": "CT head without contrast",
                "orderSentence": "Serial CT imaging CT head without contrast -"
              }
            ],
            "route": "-",
            "instructions": "sooner with ANY neurological change",
            "orderSentence": "Serial CT imaging CT head without contrast -"
          },
          "contraindications": "None",
          "monitoring": "Hemorrhage expansion; midline shift progression; new hemorrhage",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Anticoagulation reversal (if applicable)",
          "route": "-",
          "indication": "Anticoagulated patients with SDH (see 3D for specific agents)",
          "dosing": {
            "doseOptions": [
              {
                "text": "Reverse anticoagulation immediately per Section 3D",
                "orderSentence": "Anticoagulation reversal (if applicable) Reverse anticoagulation immediately per Section 3D -"
              }
            ],
            "route": "-",
            "instructions": "lower threshold for surgical consultation",
            "orderSentence": "Anticoagulation reversal (if applicable) Reverse anticoagulation immediately per Section 3D -"
          },
          "contraindications": "See Section 3D for agent-specific contraindications",
          "monitoring": "Repeat CT at 6 hours post-reversal; coagulation panel; clinical neuro status",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Neurosurgical consultation",
          "route": "-",
          "indication": "Required for ALL subdural hematomas regardless of size",
          "dosing": {
            "doseOptions": [
              {
                "text": "Consult neurosurgery",
                "orderSentence": "Neurosurgical consultation Consult neurosurgery -"
              }
            ],
            "route": "-",
            "instructions": "regardless of SDH size or clinical appearance",
            "orderSentence": "Neurosurgical consultation Consult neurosurgery -"
          },
          "contraindications": "None",
          "monitoring": "Neurosurgical assessment; surgical candidacy evaluation; ICP monitor candidacy",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Surgical referral criteria",
          "route": "-",
          "indication": "SDH meeting operative thresholds; failure of medical management",
          "dosing": {
            "doseOptions": [
              {
                "text": "Refer to neurosurgery",
                "orderSentence": "Surgical referral criteria Refer to neurosurgery -"
              }
            ],
            "route": "-",
            "instructions": "if thickness >10 mm, midline shift >5 mm, GCS decline ≥2 points, ICP >20 mmHg despite maximal medical management, or neurological deterioration",
            "orderSentence": "Surgical referral criteria Refer to neurosurgery -"
          },
          "contraindications": "None — surgical evaluation is mandatory when criteria met",
          "monitoring": "GCS trend; ICP trend; imaging progression; neurological exam",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        }
      ],
      "DVT Prophylaxis": [
        {
          "item": "Mechanical prophylaxis — SCDs",
          "route": "Bilateral lower extremity",
          "indication": "ALL TBI patients; start immediately on admission",
          "dosing": {
            "doseOptions": [
              {
                "text": "Sequential compression devices",
                "orderSentence": "Mechanical prophylaxis — SCDs Sequential compression devices bilateral"
              }
            ],
            "route": "bilateral",
            "instructions": "remove only for ambulation or skin checks",
            "orderSentence": "Mechanical prophylaxis — SCDs Sequential compression devices bilateral"
          },
          "contraindications": "Active DVT in lower extremity (consult vascular surgery); severe peripheral vascular disease",
          "monitoring": "Daily skin assessment; compliance monitoring",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Pharmacological prophylaxis — Enoxaparin",
          "route": "Subcutaneous",
          "indication": "All TBI patients after hemorrhage stability confirmed on repeat imaging",
          "dosing": {
            "doseOptions": [
              {
                "text": "40 mg",
                "orderSentence": "Pharmacological prophylaxis — Enoxaparin 40 mg SC"
              }
            ],
            "route": "SC",
            "instructions": "start 24-72h post-injury IF hemorrhage stable on repeat imaging; consult neurosurgery before initiating",
            "orderSentence": "Pharmacological prophylaxis — Enoxaparin 40 mg SC"
          },
          "contraindications": "Active intracranial hemorrhage expansion; planned neurosurgical procedure within 24h; platelet count <50K; active bleeding elsewhere",
          "monitoring": "Repeat CT confirming hemorrhage stability; anti-Xa levels if renal impairment; platelet count",
          "ED": "-",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals": [
        {
          "indication": "ALL moderate-severe TBI; any subdural hematoma, epidural hematoma, depressed skull fracture; ICP monitoring candidacy; surgical decompression evaluation",
          "timing": "STAT"
        },
        {
          "indication": "Polytrauma; concomitant thoracic, abdominal, or orthopedic injuries",
          "timing": "STAT"
        },
        {
          "indication": "Orbital fractures; visual changes; fundoscopic exam for papilledema; retinal hemorrhages (non-accidental trauma screening)",
          "timing": "URGENT"
        },
        {
          "indication": "Early rehabilitation consultation for moderate-severe TBI; functional prognosis assessment; discharge planning",
          "timing": "ROUTINE — within 48-72h of admission"
        },
        {
          "indication": "Falls in elderly (home safety evaluation); assault (law enforcement, protective orders); domestic violence screening; substance abuse",
          "timing": "ROUTINE — within 24h of admission"
        }
      ],
      "Patient / Family Instructions": [
        {
          "item": "Mild TBI return precautions",
          "instructions": "Return to ED immediately for: worsening headache not relieved by acetaminophen, repeated vomiting, increasing confusion or difficulty waking, seizure, unequal pupils, weakness on one side, clear fluid from nose or ears, slurred speech"
        },
        {
          "item": "Concussion discharge",
          "instructions": "Cognitive rest for 24-48 hours (limit screen time, reading, mental exertion); gradual return to activity as tolerated; no driving until symptom-free; follow-up with PCP or neurology in 1-2 weeks"
        },
        {
          "item": "Family education (moderate-severe)",
          "instructions": "Expect behavioral changes (irritability, impulsivity, emotional lability), sleep disturbance, headache, cognitive difficulties (memory, attention); recovery trajectory varies — most improvement in first 6-12 months; family support resources"
        },
        {
          "item": "Second impact syndrome prevention",
          "instructions": "Do NOT return to contact sports or activities with fall risk until completely symptom-free AND cleared by physician; second impact before recovery can cause fatal cerebral edema"
        }
      ],
      "Lifestyle & Prevention": [
        {
          "item": "Fall prevention"
        },
        {
          "item": "Helmet use"
        },
        {
          "item": "Seatbelt use"
        },
        {
          "item": "Alcohol moderation"
        }
      ]
    }
  }
}